Approx. Rs 17,000 / BottleGet Latest Price
|Strength / Dose||5 mg|
|Packaging Size||60 Tablets|
is an oral prescription medication approved to treat moderately to severely active rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. It also comes in an extended-release formulation, Xeljanz
XR. Both formulations contain the active ingredient tofacitinib.
The most common side effects of Xeljanz include upper respiratory tract infection
, cold-like symptoms, diarrhea
, herpes zoster infection
(shingles) and headache
. The arthritis
and ulcerative colitis medication can also cause more severe problems such as serious infections
, cancer, blood clots, and death.